Strategic Cyber Ventures poured $5 million into TrapX Security‘s latest funding round, bringing the startup’s series B capital to $14 million. TrapX makes software that automates the detection, isolation, and investigation of malware attacks on enterprise systems.
The startup, which had raised $9 million last year from Intel Capital and Liberty Israel Venture Fund to fuel global expansion, said that this new investment is a result of its positive numbers on 2015.
“The company’s momentum in healthcare especially has established TrapX as the leading supplier of deception technology to hospitals, skilled nursing facilities (SNFs), MRI/X-ray centers and large physician organizations,” said Tom Kellermann, CEO of Strategic Cyber Ventures. “We’re bullish on TrapX and expect they’ll quickly expand into additional vertical markets including finance and critical infrastructure.”